pharma · Multiple Myeloma · Not applicable - Healthy volonteers · GPCR
Structure Therapeutics
Structure Therapeutics clinical programs — 8 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 601 Gateway Blvd, Suite 900, South San Francisco, California 94080, US
- Founded
- 2017
- Employees
- 202
- Programs
- 13
- Drugs
- 7
- Patents
- 93
Structure Therapeutics projects
8 ClinicalTrials.gov programs sponsored by Structure Therapeutics.
Structure Therapeutics has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Aleniglipron
Structure Therapeutics
Obese
1 trial -
Aleniglipron or Placebo
Structure Therapeutics
Obesity, Overweight, or Chronic Weight Management
2 trials -
GPC-100
Structure Therapeutics
Multiple Myeloma
1 trial -
GSBR-1290
Structure Therapeutics
Overweight or Obesity
1 trial -
TG-0054
Structure Therapeutics
Multiple Myeloma
1 trial -
TG-0054 (2.24 mg/kg)
Structure Therapeutics
Multiple Myeloma
1 trial -
TG-0054 combined with G-CSF
Structure Therapeutics
Multiple Myeloma
1 trial -
aleniglipron or placebo
Structure Therapeutics
Obesity
1 trial
Frequently asked questions
How many clinical projects does Structure Therapeutics have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.